Capacity to supply Moderna's COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, following an agreement to set up a new production line at contract manufacturer
China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh